Section Arrow
Quote
DRUG.NASDAQ
- Bright Minds Biosciences
Quotes are at least 15-min delayed:2025/09/03 21:26 EDT
Regular Hours
Last
 43.27
+4.47 (+11.52%)
Day High 
43.5 
Prev. Close
38.8 
1-M High
46.13 
Volume 
35.15K 
Bid
38.55
Ask
43.5
Day Low
38.23 
Open
38.23 
1-M Low
32.5 
Market Cap 
275.04M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 42.19 
20-SMA 40.76 
50-SMA 33.34 
52-W High 79.02 
52-W Low 0.94 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.37/-5.92
Enterprise Value
275.08M
Balance Sheet
Book Value Per Share
5.31
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
PMNProMIS Neurosciences0.4574-0.0792-14.76%6.98PE
ADAPAdaptimmune Therapeutics plc0.0526-0.0052-9.00%-- 
CARMCarisma Therapeutics0.3699-0.0701-15.93%-- 
ETHZETHZilla Corporation2.52-0.15-5.62%-- 
STTKShattuck Labs1.28+0.27+26.73%-- 
Quotes are at least 15-min delayed：2025/09/03 21:26 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.